InvestorsHub Logo
Followers 7
Posts 591
Boards Moderated 0
Alias Born 04/18/2005

Re: None

Monday, 01/07/2013 7:40:30 PM

Monday, January 07, 2013 7:40:30 PM

Post# of 345969
From the ashes of disaster…….

Grow the roses of success!!!!!!!

While I can appreciate the “conservative” approach of analyzing the data as it relates to the 2nd line study by solely comparing the 3mg/kg group vs all others, just for grins and giggles, I would like to also see PPHM assemble a MOS chart all four “groups” IE:

3mg/kg

100% of patients confirmed to have been treated with only 1mg/kg…if that can be determined

Patients with cycles of both placebo and 1mg/kg

100% placebo

Maybe I missed the announcement whereby PPHM shared that the 3mg/kg group had reached the MOS point. Could it be that this event hasn’t occurred yet? If not, the 13 month interim number must have been surpassed by now making it 14, 15, 16 months? Isn’t Peregrine obligated to announce this if in fact it has occurred?

The newly formed “control group” will obviously be greatly skewed. If the 3mg/kg group does in fact come in somewhere in above estimated range, the difference will still be outstanding. From a logical perspective, I use the well documented historical average of the control groups as the ultimate measuring stick…making the 3mg results look awesome. 40 patients is a good sized sample.

It appears that the conservatively projected MOS numbers for the other 2 phase II trials are still flying under the radar for the mathematically challenged investors.

PPHM appears to have survived the asteroid strike. The painful dilution that we just experienced bought us 3 more months of positive MOS leverage with the other two trials as the partnering discussions begin to heat up.

Onward and upward!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News